Trial Profile
Gene Transfer for Patients With Fanconi Anemia Complementation Group A (FANCA)
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 29 Jun 2022
Price :
$35
*
At a glance
- Drugs RP-L101 (Primary) ; Filgrastim; Methylprednisolone; Plerixafor; Prednisone
- Indications Fanconi's anaemia
- Focus Adverse reactions
- Acronyms FANCA
- 22 Mar 2019 Planned primary completion date changed from 31 Dec 2027 to 17 Jul 2032.
- 19 Mar 2019 Status changed from recruiting to active, no longer recruiting.
- 12 Dec 2017 Results presented at the 59th Annual Meeting and Exposition of the American Society of Hematology